Coca-Cola reported a fourth-quarter net income of $1.46 billion, or 34 cents per share, down from $2.04 billion, or 47 cents per share, a year earlier, as fresh pandemic curbs globally closed its biggest sales drivers, such as restaurants, cinemas, and sporting events.
In response, the company accelerated its workforce restructuring and slimmed down its portfolio.
Excluding restructuring charges and other items, Coke earned 47 cents per share, topping the 42 cents per share expected by analysts surveyed by Refinitiv.
Net sales dropped 5 percent to $8.6 billion, which was below last year's $9.07 billion. It was also short of analysts' expectations of $8.63 billion.
Organic revenue, which excludes the impact of foreign currency, acquisitions, or divestitures, dropped 3 percent in the quarter.
Unit case volume, a key demand indicator, plunged fell 3 percent, improving from a compared with a 4 percent drop in the preceding quarter.
All four of Coke's beverage segments reported volume declines, with Latin America being the only geographic region to report volume growth.


Gold Prices Rise as Markets Await Trump’s Policy Announcements
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
UK Markets Face Rising Volatility as Hedge Funds Target Pound and Gilts
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Investors value green labels — but not always for the right reasons
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Instagram Outage Disrupts Thousands of U.S. Users 



